Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats

Diminished responsiveness to hypoglycemia contributes to defective counterregulation in diabetes. Pancreatic and/or circulating somatostatin are elevated in diabetes, which may inhibit counterregulatory hormone release during hypoglycemia. Thus, a selective somatostatin receptor type 2 antagonist (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Jessica T.Y., Burdett, Elena, Coy, David H., Giacca, Adria, Efendic, Suad, Vranic, Mladen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237655/
https://www.ncbi.nlm.nih.gov/pubmed/22106159
http://dx.doi.org/10.2337/db11-0690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237655/
https://www.ncbi.nlm.nih.gov/pubmed/22106159
http://dx.doi.org/10.2337/db11-0690

Ejemplares similares